Literature DB >> 12421838

Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats.

Maria Elena Rodríguez-Cabezas1, Julio Gálvez, Maria Dolores Lorente, Angel Concha, Desirée Camuesco, Shamira Azzouz, Antonio Osuna, Luis Redondo, Antonio Zarzuelo.   

Abstract

Previous studies have revealed the beneficial effects exerted by dietary fiber in human inflammatory bowel disease, which were associated with an increased production of SCFA in distal colon. The aim of the present study was to elucidate the probable mechanisms involved in the beneficial effects of a fiber-supplemented diet (5% Plantago ovata seeds) in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis, with special attention to its effects on the production of some of the mediators involved in the inflammatory response, such as tumor necrosis factor alpha (TNFalpha) and nitric oxide (NO). Rats were fed the fiber-supplemented diet for 2 wk before TNBS colitis induction and thereafter until colonic evaluation 1 wk later. The results obtained showed that dietary fiber supplementation facilitated recovery from intestinal insult as evidenced both histologically, by a preservation of intestinal cytoarchitecture, and biochemically, by a significant reduction in colonic myeloperoxidase activity and by restoration of colonic glutathione levels. This intestinal anti-inflammatory effect was associated with lower TNFalpha levels and lower NO synthase activity in the inflamed colon, showing significant differences when compared with nontreated colitic rats. Moreover, the intestinal contents from fiber-treated colitic rats showed a significantly higher production of SCFA, mainly butyrate and propionate. We conclude that the increased production of these SCFA may contribute to recovery of damaged colonic mucosa because they constitute substrates for the colonocyte and, additionally, that they can inhibit the production of proinflammatory mediators, such as TNFalpha and NO.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421838     DOI: 10.1093/jn/132.11.3263

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  36 in total

Review 1.  A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease.

Authors:  Roja Rahimi; Mohammad Reza Shams-Ardekani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 2.  Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.

Authors:  M-I Torres; A Rios
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

3.  Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.

Authors:  Federico Lara-Villoslada; Oscar de Haro; Desire Camuesco; Mónica Comalada; Javier Velasco; Antonio Zarzuelo; Jordi Xaus; Julio Galvez
Journal:  Eur J Nutr       Date:  2006-07-26       Impact factor: 5.614

4.  Hepcidin expression in colon during trinitrobenzene sulfonic acid-induced colitis in rats.

Authors:  Érica Martins Ferreira Gotardo; Gilberto de Almeida Ribeiro; Thayane Rodrigues Leite Clemente; Camila Henrique Moscato; Renata Bortolin Guerra Tomé; Thalita Rocha; José Pedrazzoli; Marcelo Lima Ribeiro; Alessandra Gambero
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Proinflammatory and anti-inflammatory cytokines present in the acute phase of experimental colitis treated with Saccharomyces boulardii.

Authors:  Nathália Nahas Grijó; Ricardo Carneiro Borra; Vera Lucia Sdepanian
Journal:  Dig Dis Sci       Date:  2009-12-09       Impact factor: 3.199

Review 6.  Diet, microorganisms and their metabolites, and colon cancer.

Authors:  Stephen J D O'Keefe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 7.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

8.  Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats.

Authors:  Hiroyuki Ito; Hiroki Tanabe; Hirokazu Kawagishi; Wada Tadashi; Tomono Yasuhiko; Kimio Sugiyama; Shuhachi Kiriyama; Tatsuya Morita
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

9.  Gene expression profiles of colonic mucosa in healthy young adult and senior dogs.

Authors:  Dong Yong Kil; Brittany M Vester Boler; Carolyn J Apanavicius; Lawrence B Schook; Kelly S Swanson
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

10.  Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines.

Authors:  Mary Ann Cox; James Jackson; Michaela Stanton; Alberto Rojas-Triana; Loretta Bober; Maureen Laverty; Xiaoxin Yang; Feng Zhu; Jianjun Liu; Suke Wang; Frederick Monsma; Galya Vassileva; Maureen Maguire; Eric Gustafson; Marvin Bayne; Chuan-Chu Chou; Daniel Lundell; Chung-Her Jenh
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.